Status:
TERMINATED
The Effect of a Diabetes Action Team in Patients Post Infrainguinal Bypass Surgery With and Without Diabetes
Lead Sponsor:
University of British Columbia
Collaborating Sponsors:
Novo Nordisk A/S
Conditions:
Type 2 Diabetes
Peripheral Vascular Disease
Eligibility:
All Genders
30+ years
Phase:
NA
Brief Summary
Diabetes is a very common illness. Approximately 4% of British Columbians have diabetes. However, at least 20% of people admitted to acute care hospitals have diabetes. People with diabetes are at a h...
Detailed Description
This trial will randomize subjects with diabetes who plan to undergo elective infrainguinal bypass surgery to receive either standard diabetes care by their admitting physician, or diabetes care under...
Eligibility Criteria
Inclusion
- Non-Diabetes:
- Fasting blood glucose \< 7.0 mmol/L or a random blood glucose of \< 11.1 mmol/L
- Diabetes:
- Poorly controlled type 2 diabetes (fasting plasma glucose greater than or equal to 7.0 or random plasma glucose greater than or equal to 10.0 mmol/L)
- Newly diagnosed type 2 diabetes (fasting plasma glucose greater than or equal to 7.0 mmol/L or random plasma glucose greater than or equal to 11.1 mmol/L)
- Age \> 30
- English-speaking
- Agrees to participate in the study and lives in the Lower Mainland
Exclusion
- Scheduled to undergo surgery other than infrainguinal bypass surgery
- Under 30 years of age
- Living outside of Lower Mainland
- Cannot speak and understand English
Key Trial Info
Start Date :
July 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00456105
Start Date
July 1 2006
End Date
March 1 2012
Last Update
January 18 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of British Columbia Gerontology & Diabetes Research Centre
Vancouver, British Columbia, Canada